We've found
10,154
archived clinical trials in
Other Indications
We've found
10,154
archived clinical trials in
Other Indications
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Updated: 8/4/2009
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome
Status: Enrolling
Updated: 8/4/2009
Click here to add this to my saved trials
Study of Arginine Metabolism and Nitric Oxide Formation in Relation to Glutamine Supply in Severely Burned Patients
Updated: 8/12/2009
Study of Arginine Metabolism and Nitric Oxide Formation in Relation to Glutamine Supply in Severely Burned Patients
Status: Enrolling
Updated: 8/12/2009
Study of Arginine Metabolism and Nitric Oxide Formation in Relation to Glutamine Supply in Severely Burned Patients
Updated: 8/12/2009
Study of Arginine Metabolism and Nitric Oxide Formation in Relation to Glutamine Supply in Severely Burned Patients
Status: Enrolling
Updated: 8/12/2009
Click here to add this to my saved trials
Effect of Glutamine Supplemented Nutrition Support on Protein and Glutamine Metabolism in Burns
Updated: 8/12/2009
Study on the Effect of Glutamine Supplemented Nutrition Support on Protein and Glutamine Metabolism in Severely Burned Patients
Status: Enrolling
Updated: 8/12/2009
Effect of Glutamine Supplemented Nutrition Support on Protein and Glutamine Metabolism in Burns
Updated: 8/12/2009
Study on the Effect of Glutamine Supplemented Nutrition Support on Protein and Glutamine Metabolism in Severely Burned Patients
Status: Enrolling
Updated: 8/12/2009
Click here to add this to my saved trials
Medical Treatment of "High-Risk" Neurofibromas
Updated: 9/22/2009
Medical Treatment of "High-Risk" Neurofibromas in Patients With Type 1 Neurofibromatosis: A Clinical Trial of Sequential Medical Therapies
Status: Enrolling
Updated: 9/22/2009
Medical Treatment of "High-Risk" Neurofibromas
Updated: 9/22/2009
Medical Treatment of "High-Risk" Neurofibromas in Patients With Type 1 Neurofibromatosis: A Clinical Trial of Sequential Medical Therapies
Status: Enrolling
Updated: 9/22/2009
Click here to add this to my saved trials
Effect and Utilization of Protected Time Among Interns on Extended Duty-Hour Call Shifts
Updated: 9/22/2009
A Prospective Cohort Study on the Effect and Utilization of Protected Time Among Interns on Extended Duty-Hour Call Shifts
Status: Enrolling
Updated: 9/22/2009
Effect and Utilization of Protected Time Among Interns on Extended Duty-Hour Call Shifts
Updated: 9/22/2009
A Prospective Cohort Study on the Effect and Utilization of Protected Time Among Interns on Extended Duty-Hour Call Shifts
Status: Enrolling
Updated: 9/22/2009
Click here to add this to my saved trials
Efficacy of Botulinum Toxin Versus Lidocaine in Treating Masticatory Myofascial Face Pain Using Ultrasound and EMG Guided Techniques
Updated: 10/8/2009
Efficacy of Botulinum Toxin Versus Lidocaine in Treating Masticatory Myofascial Face Pain Using Ultrasound and EMG Guided Techniques
Status: Enrolling
Updated: 10/8/2009
Efficacy of Botulinum Toxin Versus Lidocaine in Treating Masticatory Myofascial Face Pain Using Ultrasound and EMG Guided Techniques
Updated: 10/8/2009
Efficacy of Botulinum Toxin Versus Lidocaine in Treating Masticatory Myofascial Face Pain Using Ultrasound and EMG Guided Techniques
Status: Enrolling
Updated: 10/8/2009
Click here to add this to my saved trials
Amyloid Plaque and Tangle Imaging in Alzheimer's Disease and Down Syndrome
Updated: 12/23/2009
Amyloid Plaque and Tangle Imaging in Alzheimer's Disease and Down Syndrome
Status: Enrolling
Updated: 12/23/2009
Amyloid Plaque and Tangle Imaging in Alzheimer's Disease and Down Syndrome
Updated: 12/23/2009
Amyloid Plaque and Tangle Imaging in Alzheimer's Disease and Down Syndrome
Status: Enrolling
Updated: 12/23/2009
Click here to add this to my saved trials
Glucose Metabolic, Amyloid, and Tau Brain Imaging in Down Syndrome and Dementia
Updated: 12/23/2009
Glucose Metabolic, Amyloid, and Tau Brain Imaging in Down Syndrome and Dementia
Status: Enrolling
Updated: 12/23/2009
Glucose Metabolic, Amyloid, and Tau Brain Imaging in Down Syndrome and Dementia
Updated: 12/23/2009
Glucose Metabolic, Amyloid, and Tau Brain Imaging in Down Syndrome and Dementia
Status: Enrolling
Updated: 12/23/2009
Click here to add this to my saved trials
Effects of Vitamin D Dose and Genotype of the Binding Protein in Infants and Children
Updated: 1/14/2010
A Randomized, Controlled Trial of Vitamin D Supplementation in Infants and Children: Effects of Vitamin D Dose and Genotype of the Binding Protein
Status: Enrolling
Updated: 1/14/2010
Effects of Vitamin D Dose and Genotype of the Binding Protein in Infants and Children
Updated: 1/14/2010
A Randomized, Controlled Trial of Vitamin D Supplementation in Infants and Children: Effects of Vitamin D Dose and Genotype of the Binding Protein
Status: Enrolling
Updated: 1/14/2010
Click here to add this to my saved trials
The Clinical and Biochemical Effect of Therapeutic Massage on Fatigue and Insomnia in Women With Breast Cancer Receiving Radiation Therapy
Updated: 2/17/2010
The Clinical and Biochemical Effect of Therapeutic Massage on Fatigue and Insomnia in Women With Breast Cancer Receiving Radiation Therapy
Status: Enrolling
Updated: 2/17/2010
The Clinical and Biochemical Effect of Therapeutic Massage on Fatigue and Insomnia in Women With Breast Cancer Receiving Radiation Therapy
Updated: 2/17/2010
The Clinical and Biochemical Effect of Therapeutic Massage on Fatigue and Insomnia in Women With Breast Cancer Receiving Radiation Therapy
Status: Enrolling
Updated: 2/17/2010
Click here to add this to my saved trials
Efficacy and Safety Study of Memantine Hydrochloride in Enhancing the Cognitive Abilities of Young Adults With Down Syndrome
Updated: 4/27/2010
A Sixteen-Week, Randomized, Double Blind, Placebo-Controlled Evaluation of the Efficacy, Tolerability and Safety of Memantine Hydrochloride on Enhancing the Cognitive Abilities of Young Adults With Down Syndrome
Status: Enrolling
Updated: 4/27/2010
Efficacy and Safety Study of Memantine Hydrochloride in Enhancing the Cognitive Abilities of Young Adults With Down Syndrome
Updated: 4/27/2010
A Sixteen-Week, Randomized, Double Blind, Placebo-Controlled Evaluation of the Efficacy, Tolerability and Safety of Memantine Hydrochloride on Enhancing the Cognitive Abilities of Young Adults With Down Syndrome
Status: Enrolling
Updated: 4/27/2010
Click here to add this to my saved trials
Study to Observe the Capability to Absorb Calcium as an Measure of Adequate Levels of Vitamin D
Updated: 5/5/2010
Calcium Absorption Efficiency As An Indicator For Vitamin D Sufficiency
Status: Enrolling
Updated: 5/5/2010
Study to Observe the Capability to Absorb Calcium as an Measure of Adequate Levels of Vitamin D
Updated: 5/5/2010
Calcium Absorption Efficiency As An Indicator For Vitamin D Sufficiency
Status: Enrolling
Updated: 5/5/2010
Click here to add this to my saved trials
Food Allergy - Tubes - Adenoids (FATA) Trial
Updated: 6/28/2010
A New Approach to Otitis Media With Effusion (OME)
Status: Enrolling
Updated: 6/28/2010
Food Allergy - Tubes - Adenoids (FATA) Trial
Updated: 6/28/2010
A New Approach to Otitis Media With Effusion (OME)
Status: Enrolling
Updated: 6/28/2010
Click here to add this to my saved trials
Vitamin D Supplementation and Metabolism in Vitamin D Deficient Elderly
Updated: 7/2/2010
Effects of Vitamin D Supplementation With and With Out Exercise on Metabolic and Physical Consequences of Vitamin D Deficiency in the Elderly
Status: Enrolling
Updated: 7/2/2010
Vitamin D Supplementation and Metabolism in Vitamin D Deficient Elderly
Updated: 7/2/2010
Effects of Vitamin D Supplementation With and With Out Exercise on Metabolic and Physical Consequences of Vitamin D Deficiency in the Elderly
Status: Enrolling
Updated: 7/2/2010
Click here to add this to my saved trials
The AutoloGel™ Post-Market Surveillance (TAPS) Program
Updated: 8/20/2010
The AutoloGel™ Post-Market Surveillance (TAPS) Program
Status: Enrolling
Updated: 8/20/2010
The AutoloGel™ Post-Market Surveillance (TAPS) Program
Updated: 8/20/2010
The AutoloGel™ Post-Market Surveillance (TAPS) Program
Status: Enrolling
Updated: 8/20/2010
Click here to add this to my saved trials
The AutoloGel™ Post-Market Surveillance (TAPS) Program
Updated: 8/20/2010
The AutoloGel™ Post-Market Surveillance (TAPS) Program
Status: Enrolling
Updated: 8/20/2010
The AutoloGel™ Post-Market Surveillance (TAPS) Program
Updated: 8/20/2010
The AutoloGel™ Post-Market Surveillance (TAPS) Program
Status: Enrolling
Updated: 8/20/2010
Click here to add this to my saved trials
The AutoloGel™ Post-Market Surveillance (TAPS) Program
Updated: 8/20/2010
The AutoloGel™ Post-Market Surveillance (TAPS) Program
Status: Enrolling
Updated: 8/20/2010
The AutoloGel™ Post-Market Surveillance (TAPS) Program
Updated: 8/20/2010
The AutoloGel™ Post-Market Surveillance (TAPS) Program
Status: Enrolling
Updated: 8/20/2010
Click here to add this to my saved trials
The AutoloGel™ Post-Market Surveillance (TAPS) Program
Updated: 8/20/2010
The AutoloGel™ Post-Market Surveillance (TAPS) Program
Status: Enrolling
Updated: 8/20/2010
The AutoloGel™ Post-Market Surveillance (TAPS) Program
Updated: 8/20/2010
The AutoloGel™ Post-Market Surveillance (TAPS) Program
Status: Enrolling
Updated: 8/20/2010
Click here to add this to my saved trials
Assess Specific Kinds of Children Challenges for Neurologic Devices Study
Updated: 8/26/2010
Assess Specific Kinds of Children Challenges for Neurologic Devices Study
Status: Enrolling
Updated: 8/26/2010
Assess Specific Kinds of Children Challenges for Neurologic Devices Study
Updated: 8/26/2010
Assess Specific Kinds of Children Challenges for Neurologic Devices Study
Status: Enrolling
Updated: 8/26/2010
Click here to add this to my saved trials
Assess Specific Kinds of Children Challenges for Neurologic Devices Study
Updated: 8/26/2010
Assess Specific Kinds of Children Challenges for Neurologic Devices Study
Status: Enrolling
Updated: 8/26/2010
Assess Specific Kinds of Children Challenges for Neurologic Devices Study
Updated: 8/26/2010
Assess Specific Kinds of Children Challenges for Neurologic Devices Study
Status: Enrolling
Updated: 8/26/2010
Click here to add this to my saved trials
Assess Specific Kinds of Children Challenges for Neurologic Devices Study
Updated: 8/26/2010
Assess Specific Kinds of Children Challenges for Neurologic Devices Study
Status: Enrolling
Updated: 8/26/2010
Assess Specific Kinds of Children Challenges for Neurologic Devices Study
Updated: 8/26/2010
Assess Specific Kinds of Children Challenges for Neurologic Devices Study
Status: Enrolling
Updated: 8/26/2010
Click here to add this to my saved trials